Akero Therapeutics

Yahoo Finance • 16 days ago

Novo Nordisk has completed its acquisition of Akero Therapeutics

Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 – Novo Nordisk and Akero Therapeutics Inc. (“Akero”) (Nasdaq: AKRO) today announced that Novo Nordisk’s acquisition of Akero, announced on 9 October 2025, has been complete... Full story

Yahoo Finance • last month

Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • last month

Liver Fibrosis Research Report 2025-2035: Market Driven by Innovation from Akero, Sagimet, Inventiva, Novo Nordisk, Viking, Boston Pharma, Aligos, Boehringer Ingelheim, and 89bio

Company Logo Liver fibrosis is a growing global concern, driven by chronic conditions like hepatitis, obesity, and alcohol use. This progressive liver disease, marked by scar tissue buildup, can advance to cirrhosis or liver cancer if unt... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025

Post-hoc analyses corroborate previously reported antifibrotic effects of efruxifermin observed in 96-week Phase 2b SYMMETRY trial and indicate potential to reduce risk of disease progression in compensated cirrhosis (F4c) due to MASH Dig... Full story

Yahoo Finance • 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD)

BALA CYNWYD, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 2 months ago

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments.

Contingent value rights have become common in biotechnology deals. More than half of all transactions this year include them, according to a Jefferies report in October. Continue Reading View comments... Full story

Yahoo Finance • 2 months ago

Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

Novo Nordisk A/S Bagsværd, 5 November, 2025 - Financial report for the period 1 January 2025 to 30 September 2025 Operating profit increased by 5% in Danish kroner and 10% at constant exchange rates (CER) to DKK 95.9 billion, impacted by... Full story

Yahoo Finance • 2 months ago

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk

Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera. Continue Reading Afficher les commentaires... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC Encourages AL, FFWM, AKRO, HNI Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq – AKRO), CoreCard Corporation (NYSE – CCRD)

BALA CYNWYD, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC Investigates AKRO, CCRD, PBBK on Behalf of Shareholders

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)

BALA CYNWYD, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 2 months ago

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)... Full story

Yahoo Finance • 2 months ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

top global stories this week: HSBC, Novo Nordisk, Nikon among notable names

Most major stock indexes across the globe ended the week lower after President Donald Trump rattled markets with threats of a “massive” tariff hike [https://seekingalpha.com/news/4503345-trump-threatens-to-pull-out-of-xi-meeting-massive-ne... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus

Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story

Yahoo Finance • 2 months ago

Key deals this week: Protagonist Therapeutics, Bristol Myers, Novo Nordisk, Fifth Third Bancorp and more

Here's a list of key deals reported across sectors this week: * Protagonist Therapeutics (NASDAQ:PTGX [https://seekingalpha.com/symbol/PTGX]), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall... Full story

Yahoo Finance • 2 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 3 months ago

Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to... Full story